Volume 23, Number 1—January 2017
Letter
Invasive Infections with Multidrug-Resistant Yeast Candida auris, Colombia
Table
Identification and antifungal susceptibilities of Candida auris clinical isolates of six hospitals, northern region of Colombia, 2016*
Isolate ID |
Hospital no. |
Specimen
origin |
Biochemical identification (system) |
Pre-AFT |
VITEK cards | Etest/AMB | ||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
FLC |
MCF |
CAS |
VRC |
AMB |
24 h |
48 h |
||||||
001 | 1 | Blood | C. haemulonii (VITEK) | None | 16 | 0.12 | <0.25 | 0.25 | 8 | 0.75 | 1 | |
002 | 1 | CSF | C. tropicalis (MicroScan Walkaway) | CAS | 16 | 0.12 | <0.25 | <0.12 | 8 | 0.75 | 1 | |
003 | 1 | Blood | C. famata (API Candida) | FLC | 16 | <0.06 | <0.25 | <0.12 | 8 | 1 | 1 | |
004 | 5 | Blood | C. haemulonii (Phoenix) | FLC | 16 | 0.12 | <0.25 | 0.25 | >16 | 1 | 1.5 | |
005 | 2 | Blood | C. haemulonii (VITEK) | FLC | >64 | 0.25 | 0.5 | 2 | >16 | 1 | 1.5 | |
006 | 4 | Blood | C. haemulonii (VITEK) | None | >64 | 0.12 | <0.25 | 0.5 | 8 | 1 | 1 | |
007 | 3 | Peritoneal fluid | C. albicans (MicroScan autoSCAN) | FLC | 16 | 0.12 | <0.25 | 0.25 | 8 | 1 | 1.5 | |
008 | 2 | Blood | C. haemulonii (VITEK) | FLC | 16 | 0.12 | <0.25 | 0.25 | 8 | 0.38 | 0.75 | |
009 | 1 | Blood | C. tropicalis (MicroScan Walkaway)/ C. famata (API Candida) | FLC, CAS | 32 | 0.12 | <0.25 | 0.25 | 8 | 2 | 3 | |
010 | 5 | Bone | C. haemulonii (VITEK) | FLC, AFG, CAS | 16 | 0.12 | <0.25 | 0.25 | 8 | 0.75 | 1 | |
011 | 6 | Urine | C. haemulonii (Phoenix) | None | 32 | 0.12 | <0.25 | 0.25 | 8 | 1.5 | 1.5 | |
012 | 3 | Blood | C. albicans (MicroScan AutoSCAN) | FLC | 32 | 0.12 | <0.25 | 1 | 8 | 1 | 2 | |
013 | 3 | Blood | C. haemulonii (VITEK) | None | 32 | 0.12 | <0.25 | 1 | 8 | 0.75 | 2 | |
014 | 3 | Blood | C. haemulonii (VITEK) | FLC | >64 | 0.12 | <0.25 | 2 | 8 | 1.5 | 1.5 | |
015 | 2 | Blood | C. haemulonii (VITEK) | None | 32 | 0.12 | <0.25 | 0.25 | 8 | 0.75 | 2 | |
016 | 2 | Blood | C. haemulonii (VITEK) | FLC | >64 | 0.12 | <0.25 | 2 | >16 | 1 | 2 | |
017 |
4 |
Blood |
C. haemulonii (VITEK) |
CAS |
>64 |
0.12 |
<0.25 |
2 |
>16 |
2 |
4 |
|
MIC (mg/L) range | 16 to >64 | <0.06 to 0.25 | <0.25 to 0.5 | <0.12 to 2 | 8 to >16 | 0.38 to 2 | 0.75 to 4 | |||||
MIC50 | 32 | 0.12 | <0.25 | 0.25 | 8 | 1 | 1.5 | |||||
MIC90 | >64 | 0.12 | <0.25 | 2 | >16 | 2 | 2 |
*AFG, anidulafungin; AMB, amphotericin B; CAS, caspofungin; CSF, cerebrospinal fluid; FLC, fluconazole; ID, identification; MCF, micafungin; MIC50, minimal inhibitory concentration for 50% of yeast; MIC90, minimal inhibitory concentration for 90% of yeast; Pre-AFT, use of antifungal therapy before the isolation of C. auris; VRC, voriconazole.